Charles Schwab’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-1,568
| Closed | -$28.2K | – | 3605 |
|
2023
Q2 | $28.2K | Hold |
1,568
| – | – | ﹤0.01% | 3514 |
|
2023
Q1 | $36.8K | Hold |
1,568
| – | – | ﹤0.01% | 3404 |
|
2022
Q4 | $39.2K | Hold |
1,568
| – | – | ﹤0.01% | 3406 |
|
2022
Q3 | $50K | Hold |
1,568
| – | – | ﹤0.01% | 3329 |
|
2022
Q2 | $62K | Hold |
1,568
| – | – | ﹤0.01% | 3359 |
|
2022
Q1 | $64K | Hold |
1,568
| – | – | ﹤0.01% | 3495 |
|
2021
Q4 | $80K | Hold |
1,568
| – | – | ﹤0.01% | 3465 |
|
2021
Q3 | $102K | Hold |
1,568
| – | – | ﹤0.01% | 3377 |
|
2021
Q2 | $61K | Hold |
1,568
| – | – | ﹤0.01% | 3341 |
|
2021
Q1 | $83K | Buy |
1,568
+866
| +123% | +$45.8K | ﹤0.01% | 3395 |
|
2020
Q4 | $48K | Hold |
702
| – | – | ﹤0.01% | 3353 |
|
2020
Q3 | $27K | Hold |
702
| – | – | ﹤0.01% | 3302 |
|
2020
Q2 | $28K | Hold |
702
| – | – | ﹤0.01% | 3280 |
|
2020
Q1 | $22K | Hold |
702
| – | – | ﹤0.01% | 3193 |
|
2019
Q4 | $80K | Hold |
702
| – | – | ﹤0.01% | 3108 |
|
2019
Q3 | $23K | Hold |
702
| – | – | ﹤0.01% | 3153 |
|
2019
Q2 | $31K | Hold |
702
| – | – | ﹤0.01% | 3181 |
|
2019
Q1 | $39K | Buy |
+702
| New | +$39K | ﹤0.01% | 3172 |
|
2018
Q2 | – | Sell |
-1,790
| Closed | -$69K | – | 3134 |
|
2018
Q1 | $69K | Hold |
1,790
| – | – | ﹤0.01% | 3058 |
|
2017
Q4 | $104K | Hold |
1,790
| – | – | ﹤0.01% | 3030 |
|
2017
Q3 | $119K | Hold |
1,790
| – | – | ﹤0.01% | 3054 |
|
2017
Q2 | $152K | Buy |
+1,790
| New | +$152K | ﹤0.01% | 3065 |
|